Matthew Steliga, M.D. is a thoracic surgeon specializing in thoracic oncology and minimally invasive treatments. He currently works with patients at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences. Previously, Dr. Steliga worked at the MD Anderson Cancer Institute in Houston. Early Education and Career Dr. Steliga earned his
Mesothelioma researchers have long hoped to find a conclusive way of identifying whether a patient’s cancer was caused by exposure to asbestos, and now a group of Italian scientists say that they have accomplished that goal. Researchers from the Marche Polytechnic University in Ancona, Italy recently identified a microRNA “signature” that is consistently found in
In the aftermath of one of the deadliest fires in United Kingdom history, that country’s coroner is urging that both residents and first responders who were exposed to the conflagration need to be screened for mesothelioma and other asbestos-related illnesses as a result of asbestos exposure from the structure. Dr. Fiona Wilcox voiced her concerns
Dave Foster has been working with mesothelioma patients and their families for over a decade.
After hearing four weeks worth of evidence in a California woman’s lawsuit against pharmaceutical giant Johnson & Johnson, a jury will be deciding whether asbestos in the company’s baby powder product caused her malignant mesothelioma. During closing arguments on Thursday, Carolyn Weirick’s attorney argued that the company owed her $29 million in compensation plus additional
As the Environmental Protection Agency seems to be opening the door to introducing asbestos use back into the United States, mesothelioma patients and advocates are struggling to find a way to fight back. They might take a lesson from recent victories achieved by our neighbors to the north, in Canada. A study conducted by the
A recent decision by the Appellate Court of Illinois represents a potential landmark for those diagnosed with malignant mesothelioma, asbestos-related lung cancer, and other asbestos-related diseases. The case was brought by a husband and wife, John and Deborah Jones, who brought a claim against Pneumo Abex, Owens-Illinois and others, accusing Abex of being part of
Tubulopapillary mesothelioma is a variation of epithelioid mesothelioma, the most common cell type for this cancer. It is characterized by tubules and papillary cell architecture. There is evidence that patients with the tubulopapillary subtype of pleural or peritoneal mesothelioma have a greater life expectancy, but this is not always true. Mesothelioma Cell Types – Epithelial
Despite the fact that asbestos’ role in mesothelioma and other diseases is well established, the Environmental Protection Agency (EPA) has introduced a new rule that will make it more likely that the carcinogen will once again be used in manufacturing in the United States. Though this decision has been haled by those in the chemical
Some patients suspected of having malignant mesothelioma have a known history of exposure to asbestos, while others may not be aware that they ingested or inhaled the toxic material. Whether physicians have good reason to suspect the rare form of cancer or are simply working through a differential diagnosis, radiologists play a crucial role in